Protagenic Therapeutics, Inc.new (PTIX) Return on Equity [ROE] (2009 - 2026)
Protagenic Therapeutics, Inc.new (PTIX) posted Return on Equity [ROE] of 398.70% for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 145.37 percentage points from the prior quarter.
Protagenic Therapeutics, Inc.new (PTIX) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2024 (ended Dec 31, 2024), Protagenic Therapeutics, Inc.new's Return on Equity [ROE] came in at -3166.70%, down 3082.87 percentage points from FY2023.
- Annual Return on Equity [ROE] shows a three-year change of -3062.07 percentage points (FY2021 to FY2024).
- In prior fiscal years, Protagenic Therapeutics, Inc.new's Return on Equity [ROE] was -83.83% in FY2023 (-36.57 pp), -47.26% in FY2022 (+57.37 pp) and -104.63% in FY2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | - |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 4.66% |
| 10 | Protagenic Therapeutics, Inc.new | 850,797.76 | -4.70 Mn | - | 398.70% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 398.70% |
| Jun 30, 2026 | 253.33% |
| Mar 31, 2026 | 1,240.77% |
| Mar 31, 2024 | -581.68% |
| Dec 31, 2023 | -113.47% |
| Sep 30, 2023 | -82.13% |
| Jun 30, 2023 | -60.72% |
| Mar 31, 2023 | -47.12% |
| Dec 31, 2022 | -55.72% |
| Sep 30, 2022 | -54.82% |
| Jun 30, 2022 | -48.02% |
| Mar 31, 2022 | -52.59% |
| Sep 30, 2021 | -1,943.97% |
| Jun 30, 2021 | -98.03% |
| Dec 31, 2018 | -4,564.39% |
| Sep 30, 2018 | -557.59% |
| Jun 30, 2018 | -316.25% |
| Mar 31, 2018 | -200.44% |
| Dec 31, 2017 | -154.77% |
| Sep 30, 2017 | -118.68% |
Protagenic Therapeutics, Inc.new Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PTIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();